remember - the mirage that keytruda is a miracle drug is a result of heavy marketing - the true success rate of keytruda is what...average extends life for a year and a half or so? true success is .5%, and that can be HAHAHA "ANECDOTAL"...their best data they brag about is only a 10% real gain of melanoma survival at 10 years - not bad but no miracle...it does NOT cure ANYBODY. i called somebody out on that at a party a while ago.."hey - whats the cure rate?".... and got the bigtime stinkeye...and dont forget significant side effects, not safe by any measure - ill let you look that one up.
LET EM SQUIRM. let them declare what they are not willing to pay to survive, ALL THE WHILE LAYING OFF EMPLOYEES THAT NEED TO NOW SELL THAT BEACH HOUSE.... its a massive bluff to instill power and not ever hint at weakness. total bluff. they have been a thorn in my side for way too long.
I DO NOT WANT THEM TO BUYOUT CYTODYN - NO WAY. they dont deserve it. not even for three fingers...well, maybe
let cytodyn or another party get this to market and merck can combo all they want and watch the PD-L1 numbers skyrocket and watch how keytruda can really send their numbers to the moon. i just dont want those punks getting all the glory too.
rant over excuse my exuberance
Quote:I know a lot of longs here would happy if Merck offered to buy Cytodyn at some astronomical price. But then, I go back and read the post by Sherlock. Whether Yariv Hefez (Merck SVP) is hinting to Cytodyn or all small biotechs in general, his message is clear. “Merck is not going to get in a bidding war with others. You have to trust us because we were here long before. We will be here to help you out. Don’t just look at the numbers.”
With that said, I don’t believe Merck would offer anywhere close to what most here hope they would. Maybe he’s bluffing or maybe is just part of negotiating. But if he truly believes in what he is saying, then Merck may not be the one for Cytodyn.